Literature DB >> 6717612

A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart.

M Delhaye, J M De Smet, G Taton, P De Neef, J C Camus, J Fontaine, M Waelbroeck, P Robberecht, J Christophe.   

Abstract

Binding to muscarinic receptors was compared with adenylate cyclase inhibition in membranes derived from human heart auricles, and with inhibition of the contraction of auricular muscle fibers. In the absence of GTP, agonists recognized two classes of receptors both of which bound antagonists with the same affinity. In the presence of GTP, both classes of receptors for agonists were converted into a single low affinity state. Carbachol and oxotremorine inhibited adenylate cyclase activity by 43%, pilocarpine being less efficient (-28%). The 3 agonists exerted similar inhibitory effects on the inotropic response, in 7 out of 9 preparations of electrically- and norepinephrine-stimulated fibers. Dose-effect curves suggested that spareness (or an amplification mechanism) was implicated in the occupancy of low affinity binding sites by carbachol and oxotremorine (but not by the partial agonist pilocarpine) and the resulting inhibition of both adenylate cyclase activity and contractile force.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6717612     DOI: 10.1007/bf00506197

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Receptors for gastrointestinal hormones.

Authors:  J D Gardner
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

2.  Interaction of acetylcholine and epinephrine on heart cyclic AMP-dependent protein kinase.

Authors:  S L Keely; T M Lincoln; J D Corbin
Journal:  Am J Physiol       Date:  1978-04

3.  Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines.

Authors:  A M Watanabe; M M McConnaughey; R A Strawbridge; J W Fleming; L R Jones; H R Besch
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

4.  Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes.

Authors:  K P Minneman; L R Hegstrand; P B Molinoff
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

5.  The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue.

Authors:  L B Rosenberger; W R Roeske; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1979-06       Impact factor: 4.432

6.  GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists.

Authors:  K H Jakobs; K Aktories; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

7.  Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.

Authors:  M Waelbroeck; P Robberecht; P Chatelain; J Christophe
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

8.  Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization.

Authors:  J Z Fields; W R Roeske; E Morkin; H I Yamamura
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

9.  Agonist-antagonist interactions with rat atrial muscarinic cholinergic receptor sites: differential regulation by guanine nucleotides.

Authors:  J W Wei; P V Sulakhe
Journal:  Eur J Pharmacol       Date:  1979-09-01       Impact factor: 4.432

10.  Muscarinic receptor regulation of NG108-15 adenylate cyclase: requirement for Na+ and GTP.

Authors:  D Lichtshtein; G Boone; A Blume
Journal:  J Cyclic Nucleotide Res       Date:  1979-10
View more
  4 in total

1.  Muscarinic cholinoceptors in the human heart: demonstration, subclassification, and distribution.

Authors:  N M Deighton; S Motomura; D Borquez; H R Zerkowski; N Doetsch; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

2.  Discrimination by N-ethylmaleimide between the chronotropic and inotropic response to muscarinic receptor stimulation in rat atrium.

Authors:  H N Doods; D Davidesko; M J Mathy; H D Batink; A de Jonge; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

3.  Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium.

Authors:  S Motomura; N M Deighton; H R Zerkowski; N Doetsch; M C Michel; O E Brodde
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Muscarinic receptors mediate negative and positive inotropic effects in mammalian ventricular myocardium: differentiation by agonists.

Authors:  M Korth; V Kühlkamp
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.